AzTrials
AzTrials

Cumulative Trauma DisordersFMSNCT02091713

Musculoskeletal Injuries' Prediction Tool for Military Combatants in the Israeli Defense Force

An observational study of Cumulative Trauma Disorders, run by Sheba Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Emerging evidences indicate that performance on a variety of functional movement screens can identify athletes/soldiers at risk for injury. These field expedient tests have not been validated in a military setting or across different military occupational specialties. Read more about this study

Who is it for?
Ages 18 to 21 yearsHealthy volunteers can take part
Conditions the study is for
Cumulative Trauma Disorders
What is being tested?
Functional movement screen
How many people
300 participants
Where
1 siteIsrael
Study dates
Aug 2014to Nov 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: 300 soldiers in 3 units will be recruited and will undergo medical evaluation and functional movment screening as describes in the protocol.

Who may be able to join

  • Ages 18-21 years old
  • A combat medical profile according the IDF Medical Corp regulations
  • Hebrew speaking and reading.

Who cannot join

  • Currently seeking medical care for musculoskeletal injuries or has sought medical care for musculoskeletal injury in the last 30 days.
  • Currently unable to participate in routine physical training due to injury in foot, ankle, knee, hip, neck, shoulder, elbow, wrist, or hand injury.
  • Cardiac or pulmonary problems limiting physical activity.
  • Known history of balance or visual impairment, neurological disorders, or chronic musculoskeletal conditions precluding their involvement in military training, physical training, or sports.
  • Pregnancy, subjects that become pregnant during the course of the study will be excluded based on the different injury risk factors that are associated with musculoskeletal injury during pregnancy.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Heller institute of medical research

    Tel HaShomer

    Oren Schwarz, M.D, +972529283702, Oren.Schwarz@sheba.health.gov.il

    Oren Schwarz, M.D

Other trials in Israel

About this study

Official title: Musculoskeletal Injuries' Prediction Tool for Military Combatants in the Israeli Defense Force (FMS)

Emerging evidences indicate that performance on a variety of functional movement screens can identify athletes/soldiers at risk for injury. These field expedient tests have not been validated in a military setting or across different military occupational specialties. In this prospective study the investigators plan to screen 300 combatants for a 1-year time frame in order to validate the suggested algorithm of a list of modifiable and non-modifiable risk factors which are hypothesized to predict injury risk during the military service.

Read the detailed description

Injury data will be collected through physician exam, self-report, profile data, and healthcare utilization data. Injury data will be collected at baseline and for six iterations, every 60 days, over the course of one year following baseline. Based on the data collected, clinical prediction rules will be used to develop computerized algorithm to predict injury risk in these populations. Moreover, these results will assist in creating individualized preventing physical training program.

Being tested
Functional movement screen
Keywords
FMS, functional movement screen
Medical subject headings
Cumulative Trauma Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional movement screenOther

    The subjects will undergo movement and balance screens, measures of power, demographic data and biopsychosocial measures. Injury data will be collected through physician exam, self-report, profile data, and healthcare utilization data. Injury data will be collected at baseline and for six iterations, every 60 days, over the course of one year following baseline. Based on the data collected, clinical prediction rules will be used to develop computerized algorithm to predict injury risk in these populations.

Study groups in NCT02091713
Study groupRoleWhat they receive
Experimental/Functional movement screen300 subjects from three different combat units will undergo functional movement screening
Receives: Other: Functional movement screen

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baseline surveillance

    In this study all subjects will undergo a baseline assessment on recruitment, in which demographic, biopsychosocial, and physical data will be collected.

    Measured: 1 week

  2. Injury surveillance

    Yearly injury surveillance will be conducted on a 2-month basis in which the research team will prospectively collect data on any injury occurrence and medical health utilization among the study's subjects.

    Measured: 1 year

Secondary outcomes (2)
  1. Physical assessment

    The physical assessment of risk factors will include the following 8 tests: foot structure and mobility (foot length, seated and standing AHI), assessment of functional movement (FMS), lower extremity power (SLVJ), hop testing, lower quarter Y-Balance Test (LQYBT), and upper quarter Y Balance test (UQYBT), ankle dorsiflexion, and the 240m shuttle run as detailed.

    Measured: 1 year

  2. Demographic and biopsychosocial data

    Demographic and biopsychosocial data collection will include general information, such as: age, gender, anthropometrics (height, weight), past medical history previous sport engagements, injury in the last 12 months, past physical activities and levels, smoking status, marital status, and educational level. In addition to these demographic variables all subjects will answer questions related to biopsychosocial factors associated with injury.

    This includes questions related to job/life satisfaction, numeric pain ratings associated with depression, anxiety, frustration, anger, and fear, and completion of the patient health questionnaire (PHQ-9) which will help in determining the influence of indicators of depression on future injury risk.

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2014 (estimated)
  2. Study startAug 2014
  3. Primary completionAug 2016 (estimated)
  4. Study completionNov 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02091713
Sponsor's protocol ID
SHEBA-13-0529-BA-CTIL
Other IDs
1294-2013
Acronym
FMS
Status last verified
Mar 2014
First submitted
12 Mar 2014
Last updated
19 Mar 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cumulative Trauma Disorders, run by Sheba Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oren Schwarz, M.D (+972529283702, Oren.Schwarz@sheba.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baseline surveillance (time frame: 1 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in